- Markets
- Trading
- CRAVATEX
CRAVATEX
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
This data is currently unavailable for this company.
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Cravatex do?
Cravatex Ltd is a company that specializes in importing and distributing a wide range of products, including sports equipment, apparel, and beauty therapy services, in addition to manufacturing and selling sports and casual wear.
Who are the competitors of Cravatex?
Cravatex major competitors are Astal Laboratories, Rajlaxmi Industries, Euro Asia Exports, Silkflex Polymers, Synoptics Techno., Rama Vision, Welcure Drugs&Pharma. Market Cap of Cravatex is ₹86 Crs. While the median market cap of its peers are ₹88 Crs.
Is Cravatex financially stable compared to its competitors?
Cravatex seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Cravatex pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Cravatex latest dividend payout ratio is 16.06% and 3yr average dividend payout ratio is 8.36%
How has Cravatex allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Cravatex balance sheet?
Balance sheet of Cravatex is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Cravatex improving?
No, profit is decreasing. The profit of Cravatex is ₹3.89 Crs for TTM, ₹4.83 Crs for Mar 2024 and ₹58.93 Crs for Mar 2023.
Is the debt of Cravatex increasing or decreasing?
Yes, The debt of Cravatex is increasing. Latest debt of Cravatex is -₹73.14 Crs as of Sep-24. This is greater than Mar-24 when it was -₹152.1 Crs.
Is Cravatex stock expensive?
Cravatex is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Cravatex is 22.12, while 3 year average PE is 6.02. Also latest EV/EBITDA of Cravatex is 0.0 while 3yr average is 16.26.
Has the share price of Cravatex grown faster than its competition?
Cravatex has given lower returns compared to its competitors. Cravatex has grown at ~-26.21% over the last 1yrs while peers have grown at a median rate of 45.0%
Is the promoter bullish about Cravatex?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Cravatex is 75.0% and last quarter promoter holding is 75.0%.
Are mutual funds buying/selling Cravatex?
There is Insufficient data to gauge this.